A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
for Upper Urinary Tract Urothelial Carcinoma
23 locations incl. Homewood
Sponsor: UroGen Pharma Ltd.
Sex: All·Age: 18+
Code: NCT06774131·Phase 3·Recruiting